Literature DB >> 26350809

Validation of the Pooled Cohort equations in a long-term cohort study of Hong Kong Chinese.

Chi Ho Lee1, Yu Cho Woo1, Joanne K Y Lam1, Carol H Y Fong1, Bernard M Y Cheung2, Karen S L Lam2, Kathryn C B Tan3.   

Abstract

BACKGROUND: The 2013 American College of Cardiology and the American Heart Association guidelines recommended the Pooled Cohort equations for evaluation of cardiovascular (CV) risk of individuals.
OBJECTIVE: We investigated the usefulness of the Pooled Cohort equations in Chinese by validating this risk prediction model using the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort.
METHODS: The Hong Kong CRISPS is a population-based prospective cohort study of CV risk factors among 2895 Chinese men and women (aged 25-74 years) initiated in 1995. CV events were ascertained until December 2012. The discrimination and calibration of the Pooled Cohort equations were evaluated and compared with the Framingham CV risk equation. A Hosmer-Lemeshow chi-square statistic (X(2)) of <20 indicated good calibration.
RESULTS: The discrimination power of the 2 models in both men and women was moderate. The calibration score of both models were unacceptable in men (Pooled Cohort X(2), 24.1; Framingham X(2), 20.1), but was satisfactory in women (10.1 and 12.1, respectively). In men, with recalibration of the model using the CRISPS data, the accuracy of prediction improved. Recalibration, however, could not be applied to the Pooled Cohort model because the degree of miscalibration varied across the different risk categories.
CONCLUSIONS: The Pooled Cohort equations provide poor calibration and moderate discrimination in Hong Kong Chinese, especially in men. In contrast, the Framingham CV risk equation can be applied to the Chinese population but requires recalibration in men.
Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Cholesterol; Primary prevention; Statins; Validation studies

Mesh:

Year:  2015        PMID: 26350809     DOI: 10.1016/j.jacl.2015.06.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  15 in total

1.  Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.

Authors:  Fatima Rodriguez; Sukyung Chung; Manuel R Blum; Adrien Coulet; Sanjay Basu; Latha P Palaniappan
Journal:  J Am Heart Assoc       Date:  2019-07-11       Impact factor: 6.106

2.  Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.

Authors:  Johanna A Damen; Romin Pajouheshnia; Pauline Heus; Karel G M Moons; Johannes B Reitsma; Rob J P M Scholten; Lotty Hooft; Thomas P A Debray
Journal:  BMC Med       Date:  2019-06-13       Impact factor: 8.775

3.  Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China.

Authors:  Yunxing Jiang; Xianghui Zhang; Rulin Ma; Xinping Wang; Jiaming Liu; Mulatibieke Keerman; Yizhong Yan; Jiaolong Ma; Yanpeng Song; Jingyu Zhang; Jia He; Shuxia Guo; Heng Guo
Journal:  Clin Epidemiol       Date:  2021-06-09       Impact factor: 4.790

4.  Prediction of 8-year risk of cardiovascular diseases in Korean adult population.

Authors:  Sung Hyouk Choi; Seung Min Lee; Su Hwan Kim; Minseon Park; Hyung-Jin Yoon
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

5.  Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Christopher L Schaich; Joseph Yeboah; Mark A Espeland; Laura D Baker; Jingzhong Ding; Kathleen M Hayden; Bonnie C Sachs; Suzanne Craft; Stephen R Rapp; José A Luchsinger; Annette L Fitzpatrick; Susan R Heckbert; Wendy S Post; Gregory L Burke; Norrina B Allen; Timothy M Hughes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-06-01       Impact factor: 6.591

6.  Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data.

Authors:  Julian Wolfson; David M Vock; Sunayan Bandyopadhyay; Thomas Kottke; Gabriela Vazquez-Benitez; Paul Johnson; Gediminas Adomavicius; Patrick J O'Connor
Journal:  J Am Heart Assoc       Date:  2017-04-24       Impact factor: 5.501

7.  Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.

Authors:  Jae Hyun Bae; Min Kyong Moon; Sohee Oh; Bo Kyung Koo; Nam Han Cho; Moon Kyu Lee
Journal:  Diabetes Metab J       Date:  2020-01-13       Impact factor: 5.376

8.  Association of Impaired Vascular Endothelial Function with Increased Cardiovascular Risk in Asymptomatic Adults.

Authors:  Qiuan Zhong; Qingjiao Nong; Baoyu Mao; Xue Pan; Liuren Meng
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

9.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.

Authors:  Rohan Khera; Yuan Lu; Jiapeng Lu; Anshul Saxena; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  BMJ       Date:  2018-07-11

10.  Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.

Authors:  Vidya P Menon; Fabia Edathadathil; Dipu Sathyapalan; Merlin Moni; Ann Don; Sabarish Balachandran; Binny Pushpa; Preetha Prasanna; Nithu Sivaram; Anupama Nair; Nithu Vinod; Rekha Jayaprasad; Veena Menon
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.